Developing a novel therapy for kidney cancer

• Unité de recherche: INNOSUISSE
• Numéro de projet: 132.430 IP-LS
• Titre du projet anglais: Developing a novel therapy for kidney cancer

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

This collaborative project aims to develop and preclinically characterize a novel radioligand therapy based on an alginate-based delivery system carrying a radium-223 payload, specifically targeting Carbonic Anhydrase IX (CAIX), a validated marker in clear cell renal cell carcinoma (ccRCC).